These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta-analysis. Jensen AH; Winther-Sørensen M; Burisch J; Bergquist A; Ytting H; Gluud LL; Wewer Albrechtsen NJ Liver Int; 2023 Nov; 43(11):2479-2491. PubMed ID: 37752719 [TBL] [Abstract][Full Text] [Related]
3. Extrahepatic autoimmunity in autoimmune liver disease. Floreani A; De Martin S; Secchi MF; Cazzagon N Eur J Intern Med; 2019 Jan; 59():1-7. PubMed ID: 30360943 [TBL] [Abstract][Full Text] [Related]
4. To screen or not to screen? Celiac antibodies in liver diseases. Narciso-Schiavon JL; Schiavon LL World J Gastroenterol; 2017 Feb; 23(5):776-791. PubMed ID: 28223722 [TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of Autoimmune Liver Disease]. Heo NY Korean J Gastroenterol; 2023 Feb; 81(2):59-65. PubMed ID: 36824033 [TBL] [Abstract][Full Text] [Related]
7. [Research advances of autoimmune liver diseases in 2018]. Chen Y; Wang QX; Ma X Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):14-17. PubMed ID: 30685918 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children. Lee WS; Karthik SV; Ng RT; Ong SY; Ong C; Chiou FK; Wong SY; Quak SH; Aw MM Pediatr Neonatol; 2019 Aug; 60(4):396-404. PubMed ID: 31409456 [TBL] [Abstract][Full Text] [Related]
9. The management of autoimmunity in patients with cholestatic liver diseases. Ali AH; Carey EJ; Lindor KD Expert Rev Gastroenterol Hepatol; 2016; 10(1):73-91. PubMed ID: 26523975 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology and updated management for autoimmune liver disease. Heo NY; Kim H Clin Mol Hepatol; 2023 Jan; 29(1):194-196. PubMed ID: 36521451 [No Abstract] [Full Text] [Related]
11. [Treatment of autoimmune hepatic diseases]. Bueverov AO Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604 [TBL] [Abstract][Full Text] [Related]
13. The overlap syndromes of autoimmune hepatitis. Czaja AJ Dig Dis Sci; 2013 Feb; 58(2):326-43. PubMed ID: 22918690 [TBL] [Abstract][Full Text] [Related]
14. Overlap syndromes of autoimmune hepatitis: an open question. Durazzo M; Premoli A; Paschetta E; Belci P; Spandre M; Bo S Dig Dis Sci; 2013 Feb; 58(2):344-8. PubMed ID: 23086110 [TBL] [Abstract][Full Text] [Related]
15. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective. Kingham JG; Abbasi A Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1077-80. PubMed ID: 16148553 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence. Yabiku K Front Endocrinol (Lausanne); 2021; 12():768850. PubMed ID: 34950104 [TBL] [Abstract][Full Text] [Related]
19. [Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties]. Hagymási K; Tulassay Z Orv Hetil; 2013 Jun; 154(24):923-9. PubMed ID: 23752047 [TBL] [Abstract][Full Text] [Related]
20. Is the new diagnostic scoring system of Zeniya and colleagues useful for autoimmune liver diseases? Horiike N; Onji M J Gastroenterol; 2005 Dec; 40(12):1163-6. PubMed ID: 16378184 [No Abstract] [Full Text] [Related] [Next] [New Search]